Drug Search Results
More Filters [+]

PDI-192

Alternative Names: pdi-192, pdi192, pdi 192
Latest Update: 2014-05-29
Latest Update Note: Clinical Trial Update

Product Description

Treatment of Mild to Moderate Atopic Dermatitis

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: PreCision Dermatology
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for PDI-192

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Dermatitis, Atopic

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

NCT01826461

P2

Completed

Dermatitis, Atopic

2013-12-01

Recent News Events

Date

Type

Title